Among the food that has been recalled for contamination risks since the 111th Congress convened: -Eggs (500,000,000+) -spinach -peanuts/peanut butter -pistachios -tomatoes -jalapenos -70,000 lbs of cheese Among contaminated or recalled drugs suspected of

During this lame-duck session of Congress, the House of Representatives took action and, against the odds, passed the child nutrition reauthorization (CNR) bill. The Healthy, Hunger-Free Kids Act of 2010 (S. 3307), already passed by the Senate. First Lady

Beyond their traditional duties of legally representing state agencies and serving as an advisor to the Governor, state attorneys general over the last two decades have proven themselves defenders of everyday people in the name of the public good. One def

Is a few thousand dollars worth of health care coverage really insurance? Senator Jay Rockefeller (D-WV) raised this question at a December 1 hearing appropriately entitled Are Mini-Med Policies Really Health Insurance? As chair of the Senate Commerce, Sc

In the year after drugmakers removed over-the-counter cough and cold medications for infants and toddlers from shelves, emergency room visits for kids under age two linked to overdose and adverse events were halved. In a study in the current issue of Pedi

Right now millions of people qualify for Medicaid and other public benefits but are not enrolled. Failure to modernize the outreach and enrollment process is a major reason why so many people are falling through the cracks of the health system. Banks have

The safety and integrity of the global drug supply chain stands among the FDA's major proposed priorities for the next four years. We support this plan wholeheartedly, as the challenges of globalization have far-outstripped the FDA’s resources for inspect

Massachusetts’ health reform law generated a great deal of attention during the debate on national health reform. As implementation of the new law moves forward, Massachusetts reform continues to remain in the spotlight, but not always in a good way. Affo

Three headlines that caught our eye over the weekend: FDA report suggests it’s not quite time for J&J to cut the ribbon on its brand-recovery campaign. The New York Times looks at the most recent inspection report the agency filed on J&J’s trouble